Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Raw Materials: 2020-2025

Historic Raw Materials for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $16.0 million.

  • Maravai Lifesciences Holdings' Raw Materials fell 3.81% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 3.81%. This contributed to the annual value of $17.0 million for FY2024, which is 12.22% down from last year.
  • Maravai Lifesciences Holdings' Raw Materials amounted to $16.0 million in Q3 2025, which was down 2.44% from $16.4 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Raw Materials ranged from a high of $26.8 million in Q3 2023 and a low of $13.5 million during Q4 2022.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Raw Materials value was $17.2 million (recorded in 2025), while the average stood at $18.9 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Raw Materials surged by 77.52% in 2021, and later slumped by 37.79% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Raw Materials (Quarterly) stood at $19.7 million in 2021, then crashed by 31.63% to $13.5 million in 2022, then spiked by 43.39% to $19.3 million in 2023, then dropped by 12.22% to $17.0 million in 2024, then declined by 3.81% to $16.0 million in 2025.
  • Its Raw Materials was $16.0 million in Q3 2025, compared to $16.4 million in Q2 2025 and $17.2 million in Q1 2025.